Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core …
Over the last 12 months, insiders at Intuitive Surgical, Inc. have bought $0 and sold $131.97M worth of Intuitive Surgical, Inc. stock.
On average, over the past 5 years, insiders at Intuitive Surgical, Inc. have bought $0 and sold $104.48M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000 shares for transaction amount of $500,373 was made by Johnson Amal M (director) on 2010‑11‑19.
2024-10-30 | Sale | CEO | 25,591 0.0072% | $511.34 | $13.09M | -1.45% | ||
2024-10-29 | Sale | EVP & Chief Strategy & Corp Op | 188 <0.0001% | $506.52 | $95,226 | -1.83% | ||
2024-10-28 | Sale | EVP & Chief Strategy & Corp Op | 198 <0.0001% | $513.66 | $101,705 | 0.00% | ||
2024-10-28 | Sale | SVP & Chief Mfg and Supply Cha | 22 <0.0001% | $513.66 | $11,301 | +0.52% | ||
2024-10-25 | Sale | EVP & Chief Strategy & Corp Op | 188 <0.0001% | $514.00 | $96,632 | 0.00% | ||
2024-10-25 | Sale | SVP & Chief Mfg and Supply Cha | 22 <0.0001% | $514.00 | $11,308 | 0.00% | ||
2024-10-24 | Sale | SVP & Chief Mfg and Supply Cha | 22 <0.0001% | $510.79 | $11,237 | 0.00% | ||
2024-10-23 | Sale | SVP & Chief Mfg and Supply Cha | 22 <0.0001% | $513.89 | $11,306 | 0.00% | ||
2024-10-22 | Sale | EVP & Chief Digital Officer | 2,553 0.0007% | $515.00 | $1.31M | 0.00% | ||
2024-10-22 | Sale | SVP & Chief Mfg and Supply Cha | 2,128 0.0006% | $515.00 | $1.1M | 0.00% | ||
2024-09-13 | Sale | director | 450 0.0001% | $490.28 | $220,626 | -0.70% | ||
2024-09-10 | Sale | EVP & Chief Strategy & Corp Op | 119 <0.0001% | $477.50 | $56,823 | +0.59% | ||
2024-09-09 | Sale | General Counsel | 300 <0.0001% | $475.00 | $142,500 | +1.51% | ||
2024-08-29 | Sale | EVP & Chief Strategy & Corp Op | 188 <0.0001% | $482.21 | $90,655 | -0.49% | ||
2024-08-28 | Sale | EVP & Chief Strategy & Corp Op | 188 <0.0001% | $482.93 | $90,791 | +0.68% | ||
2024-08-26 | Sale | EVP & Chief Strategy & Corp Op | 198 <0.0001% | $486.88 | $96,402 | +1.16% | ||
2024-08-23 | Sale | SVP & Chief Commercial and Mkt | 1,758 0.0005% | $486.84 | $855,864 | -0.37% | ||
2024-08-23 | Sale | SVP & Chief Commercial and Mkt | 22,702 0.0064% | $486.84 | $11.05M | -0.37% | ||
2024-08-12 | Sale | EVP & Chief Strategy & Corp Op | 120 <0.0001% | $464.76 | $55,771 | +4.13% | ||
2024-08-01 | Sale | director | 2,943 0.0008% | $443.30 | $1.3M | +7.21% |
Johnson Amal M | director | 12275 0.0034% | $514.60 | 2 | 19 | +29.94% |
The Vanguard Group | $12.32B | 8.7 | 30.87M | +1.62% | +$196.8M | 0.23 | |
BlackRock | $12.1B | 8.55 | 30.32M | +3.69% | +$430.12M | 0.26 | |
T. Rowe Price | $6.6B | 4.66 | 16.53M | -2.61% | -$176.8M | 0.81 | |
State Street | $6.04B | 4.27 | 15.13M | +1.15% | +$68.48M | 0.25 | |
Fidelity Investments | $3.62B | 2.56 | 9.06M | +20.22% | +$608.5M | 0.24 |